Concepedia

Daniel H. Deon

DH

5

Publications

156

Citations

5

H-Index

2001

Active since

Affiliations

Université de Montréal(Current)

Institute for Research in Immunology and Cancer

Bristol-Myers Squibb (United States)

Centre in Green Chemistry and Catalysis

PROTEO

Daniel H. Deon is an author at Université de Montréal specializing in natural sciences, molecular biology, and drug discovery.

Top concepts

Publications per year

2001–2022

5

Publications

5

The effects of NS5A inhibitors on NS5A phosphorylation, polyprotein processing and localization

Dike Qiu, Julie A. Lemm, Donald R. O’Boyle et al. · Journal of General Virology · 2011 · 60 citations

, , +23

Total Synthesis of (+)-Arteanniun M Using the Tandem Oxy-Cope/Ene Reaction

Louis Barriault, Daniel H. Deon · Organic Letters · 2001 · 46 citations

Discovery of Two Novel Antiplatelet Clinical Candidates (BMS-986120 and BMS-986141) That Antagonize Protease-Activated Receptor 4

E. Scott Priestley, Jacques Banville, Daniel H. Deon et al. · Journal of Medicinal Chemistry · 2022 · 26 citations · Full text

Dual-Target Inhibitors of the Folate Pathway Inhibit Intrinsically Trimethoprim-Resistant DfrB Dihydrofolate Reductases

Jacynthe L. Toulouse, Genbin Shi, Claudèle Lemay-St-Denis et al. · ACS Medicinal Chemistry Letters · 2020 · 14 citations · Full text

, , +14

Structure-Based Design of Dimeric Bisbenzimidazole Inhibitors to an Emergent Trimethoprim-Resistant Type II Dihydrofolate Reductase Guides the Design of Monomeric Analogues

Jacynthe L. Toulouse, Brahm J. Yachnin, Edward H. Ruediger et al. · ACS Omega · 2019 · 10 citations · Full text

Rows per page

1–5 of 5